Immune Reconstitution Dynamics in HIV-Tuberculosis Co-Infection

The interplay between human immunodeficiency virus (HIV) and Mycobacterium tuberculosis presents a unique challenge when antiretroviral therapy (ART) restores pathogen-specific immunity. In co-infected individuals, profound CD4 T-cell depletion impairs granuloma integrity and permits disseminated tuberculosis (TB). Rapid immune recovery upon ART initiation can paradoxically unleash an exaggerated inflammatory response, termed tuberculosis-associated immune reconstitution inflammatory syndrome (TB-IRIS). Clinical manifestations range from fever and lymphadenopathy to life-threatening pulmonary or central nervous system inflammation. Risk factors include low pre-ART CD4 counts, high mycobacterial antigen burden, and brief intervals between TB treatment and ART. Underlying mechanisms involve a shift from monocyte-driven innate activation to robust Th1 and Th17 responses, with excessive cytokine release and matrix remodelling. Better understanding of these dynamics is critical for early identification of at-risk patients, optimisation of ART timing and development of host-directed therapies to mitigate immunopathology without compromising microbial control.

Research from Nature Portfolio

Transcriptomic profiling has revealed that, within days of ART initiation, patients who develop TB-IRIS show upregulated expression of innate immune mediators, notably Toll-like receptor pathways and inflammasome components. Early elevations in caspase-1 and caspase-5 transcripts and plasma IL-1β and IL-6 levels precede clinical onset. Functional assays demonstrate that inhibition of MyD88 adaptor signalling or group-1 caspases reduces proinflammatory cytokine secretion, pinpointing potential molecular targets for intervention. Such predictive signatures may enable pre-emptive therapy to prevent severe IRIS events.

Immune Reconstitution Dynamics in HIV-Tuberculosis Co-Infection publication trend

The graph below shows the total number of articles in immune reconstitution dynamics in hiv-tuberculosis co-infection across all publications each year (not limited to Nature Index journals).

Technical terms

Immune reconstitution inflammatory syndrome (IRIS): A dysregulated inflammatory response against existing pathogens triggered by rapid restoration of immune function after ART.

Caspase: A family of intracellular proteases that, when activated via inflammasomes, process pro-inflammatory cytokines such as IL-1β.

Matrix metalloproteinases (MMPs): Zinc-dependent enzymes secreted by neutrophils and macrophages that degrade extracellular matrix, contributing to tissue pathology in TB-IRIS.

Toll-like receptor (TLR) signalling: Innate immune pathway recognising conserved microbial molecules and initiating inflammatory gene expression.

References

1. Mycobacterial Antigen Driven Activation of CD14++CD16− Monocytes Is a Predictor of Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome. PLOS Pathogens (2014).
2. HIV–tuberculosis-associated immune reconstitution inflammatory syndrome is characterized by Toll-like receptor and inflammasome signalling. Nature Communications (2015).
3. Tuberculosis IRIS: Pathogenesis, Presentation, and Management across the Spectrum of Disease. Life (2020).
4. Matrix Degradation in Human Immunodeficiency Virus Type 1–Associated Tuberculosis and Tuberculosis Immune Reconstitution Inflammatory Syndrome: A Prospective Observational Study. Clinical Infectious Diseases (2017).
5. HIV-1 tuberculosis-associated immune reconstitution inflammatory syndrome. Seminars in Immunopathology (2015).